(Q51569051)

7 April 2018

title

Zinc supplementation improves glucose disposal in patients with cirrhosis. (English)

1 reference

7 April 2018

author

Giulio Marchesini

1

1 reference

7 April 2018

Karl Thomaseth

5

1 reference

7 April 2018

author name string

Bugianesi E

2

1 reference

7 April 2018

Ronchi M

3

1 reference

7 April 2018

Flamia R

4

1 reference

7 April 2018

Pacini G

6

1 reference

7 April 2018

publication date

1 July 1998

1 reference

7 April 2018

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Metabolism

1 reference

7 April 2018

volume

47

1 reference

7 April 2018

issue

7

1 reference

7 April 2018

page(s)

792-798

1 reference

7 April 2018

Zinc supplementation reduces blood ammonia and increases liver ornithine transcarbamylase activity in experimental cirrhosis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990114-7

Cirrhosis and diabetes. II. Association of impaired glucose tolerance with portal-systemic shunting in Laennec's cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990114-7

Insulin resistance is the main determinant of impaired glucose tolerance in patients with liver cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990114-7

Abnormal zinc metabolism in type II diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990114-7

Tissue zinc status of genetically diabetic and streptozotocin-induced diabetic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990114-7

The reduced secretion of, and sensitivity to insulin in zinc-deficient rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990114-7

Effects of oral zinc gluconate on glucose effectiveness and insulin sensitivity in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990114-7

Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990114-7

Role of zinc supplementation in type II diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990114-7

Mathematical models of insulin secretion in physiological and clinical investigations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990114-7

Treatment with a somatostatin analog decreases pancreatic B-cell and whole body sensitivity to glucose.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990114-7

Insulin secretion and hepatic extraction in humans by minimal modeling of C-peptide and insulin kinetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990114-7

The effect of zinc on insulin metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990114-7

Insulinomimetic properties of trace elements and characterization of their in vivo mode of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990114-7

Role of divalent metals in the activation and regulation of insulin receptor tyrosine kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990114-7

Hyperzincuria in IDDM women. Relationship to measures of glycemic control, renal function, and tissue catabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990114-7

Hyperzincuria in individuals with insulin-dependent diabetes mellitus: concurrent zinc status and the effect of high-dose zinc supplementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990114-7

Zinc metabolism in hepatic dysfunction. I. Serum zinc concentrations in Laënnec's cirrhosis and their validation by sequential analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990114-7

Zinc Metabolism in Alcoholic Liver Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990114-7

Insulin sensitivity, insulin secretion and glucose effectiveness in diabetic and non-diabetic cirrhotic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990114-7

Role of glucose effectiveness in the determination of glucose tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990114-7

Normal splanchnic but impaired peripheral insulin-stimulated glucose uptake in cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990114-7

Insulin uptake by the human alcoholic cirrhotic liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990114-7

Importance of glucose per se to intravenous glucose tolerance. Comparison of the minimal-model prediction with direct measurements.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990114-7

Facilitated diffusion of glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990114-7

Hyperglycemia Activates Glucose Transport in Rat Skeletal Muscle Via a Ca2+-Dependent Mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990114-7

Zinc deficiency in women, infants and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990114-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990114-7

Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990114-7

Insulin-like growth factor-1 therapy in diabetes: physiologic basis, clinical benefits, and risks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990114-7

High insulin-like growth factor binding protein 1 levels in cirrhosis: link with insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2898%2990114-7

10.1016/S0026-0495(98)90114-7

7 January 2021

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018